Bausch & Lomb Akreos® AO IOL Granted New Technology Intraocular Lens (NTIOL) Designation

May 12, 2009

Bausch & Lomb announced today that the Centers for Medicare and Medicaid Services (CMS) granted a New Technology Intraocular Lens (NTIOL) designation to the company’s Akreos® Advanced Optics Aspheric (Akreos AO) IOL for its spherical aberration reducing design. The NTIOL designation became effective April 30, 2009.

NTIOL designation means the Medicare reimbursement to ambulatory surgery centers for cataract surgery will increase by $50 when surgery is performed with the Akreos AO IOL. This NTIOL subset and adjusted payment for this IOL will remain in effect until February 26, 2011.

Read the full release




Jump down to form below to submit your own comments

Comments are closed.